Repeat Dose Safety Study for Compound to Treat Hematologic Cancer

Clinical trial NCT00881946 · COMPLETED

Trial details

NCT number: NCT00881946
Sponsor: Accenture
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2009-07-01
Primary completion: 2012-03-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.